1. Home
  2. BROG vs COYA Comparison

BROG vs COYA Comparison

Compare BROG & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BROG
  • COYA
  • Stock Information
  • Founded
  • BROG 2019
  • COYA 2020
  • Country
  • BROG United Arab Emirates
  • COYA United States
  • Employees
  • BROG N/A
  • COYA N/A
  • Industry
  • BROG Integrated oil Companies
  • COYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BROG Energy
  • COYA Health Care
  • Exchange
  • BROG Nasdaq
  • COYA Nasdaq
  • Market Cap
  • BROG 131.5M
  • COYA 108.4M
  • IPO Year
  • BROG N/A
  • COYA 2022
  • Fundamental
  • Price
  • BROG $1.22
  • COYA $5.26
  • Analyst Decision
  • BROG
  • COYA Strong Buy
  • Analyst Count
  • BROG 0
  • COYA 4
  • Target Price
  • BROG N/A
  • COYA $17.00
  • AVG Volume (30 Days)
  • BROG 7.7K
  • COYA 66.8K
  • Earning Date
  • BROG 04-29-2025
  • COYA 05-08-2025
  • Dividend Yield
  • BROG N/A
  • COYA N/A
  • EPS Growth
  • BROG N/A
  • COYA N/A
  • EPS
  • BROG N/A
  • COYA N/A
  • Revenue
  • BROG $73,020,415.00
  • COYA $3,554,061.00
  • Revenue This Year
  • BROG N/A
  • COYA $94.45
  • Revenue Next Year
  • BROG N/A
  • COYA N/A
  • P/E Ratio
  • BROG N/A
  • COYA N/A
  • Revenue Growth
  • BROG N/A
  • COYA N/A
  • 52 Week Low
  • BROG $0.80
  • COYA $4.65
  • 52 Week High
  • BROG $2.14
  • COYA $10.24
  • Technical
  • Relative Strength Index (RSI)
  • BROG 50.77
  • COYA 40.06
  • Support Level
  • BROG $1.06
  • COYA $5.08
  • Resistance Level
  • BROG $1.22
  • COYA $5.60
  • Average True Range (ATR)
  • BROG 0.08
  • COYA 0.54
  • MACD
  • BROG -0.00
  • COYA -0.05
  • Stochastic Oscillator
  • BROG 67.86
  • COYA 29.47

About BROG Brooge Energy Limited

Brooge Energy Ltd is an Oil Refinery & Storage Company in the United Arab Emirates. The company generates revenue from the leasing of storage capacity of tanks and other ancillary services.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Share on Social Networks: